Unilife Corporation announces it has launched www.Unitract.com to support the commercial release of its Unitract™ 1 mL clinical safety syringes. The Web site contains in-depth product information on Unitract™’s technology, features and benefits, as well as product variants and availability, a section with downloadable training materials, and videos that provide a detailed look at functionality.
Unitract™ syringes provide an automatic choice for safe, simple injections. A uniquely passive safety mechanism allows operators to control the rate of needle retraction directly from the body to help protect those at risk of infection from needlestick injuries and aerosol. U.S.-made and intuitive for use, Unitract™ 1mL syringes are helping to redefine injection safety standards for healthcare workers and patients who self-administer prescription medication.
